In the current review, we examine the evidence for reduced formation of blood vessels in DMD muscle and the therapeutic approach to augment angiogenesis by using vascular endothelial growth factor (VEGF)-based strategies. Here, VEGFA is linked to Duchenne muscular dystrophy.